Neuroinflammation

Part of Neurologic Diseases

🏥2Companies

Companies in Neuroinflammation

AI-generated hero image for BenevolentAI

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

BenevolentAI

Acquired

London, UK

BenevolentAI, founded in 2013 and headquartered in London, United Kingdom, is a drug discovery company that was delisted from Euronext Amsterdam and merged with Osaka Holdings S...

...more

Business ModelB2B (collaborations with pharmaceutical companies, commercializing knowledge exploration tools), In-house drug development (advancing own drug pipeline).

Core TechBenevolent Platform™ - an end-to-end computational and ex...

Funding$282.0M

Founded2013

Drug Discovery/Development

Get Involved in BenevolentAI

Exscientia

Public

Oxford, United Kingdom

Exscientia is an AI-driven drug design and development company, founded in 2012, pioneering precision medicine to discover new therapies faster. It uses AI throughout the drug d...

...more

Business ModelExscientia operates with a "full-stack" AI drug discovery model, developing its proprietary pipeline and forming collaborations with major pharmaceutical companies. It generates revenue through upfront payments, milestone payments, and potential royalties from these partnerships.

Core Techgenerative artificial intelligence (AI) to discover new t...

Funding$510.0M

Founded2012

Drug Discovery/Development

Too Big!

Get Involved in Exscientia